Literature DB >> 8195591

Preparation of F(ab')2 mu fragments from rat IgM monoclonal antibodies and their application to the enzyme immunoassay of mouse interleukin-6.

K Inouye1, K Morimoto.   

Abstract

F(ab')2 fragments, herein designated as F(ab')2 mu, were prepared from rat IgM monoclonal antibodies (mAbs). The IgM was digested at a pepsin-to-IgM ratio of 1:200 (w/w) in 100 mM citrate buffer (pH 4.5) at 37 degrees C for 2 h. During digestion, the light (L) chain (27 kDa) of IgM remained undegraded, whereas the heavy (H) chain disappeared and two new bands of 44 and 48 kDa appeared. The digests were fractionated by means of hydrophobic interaction HPLC with TSKgel Phenyl-5PW. The fraction containing F(ab')2 mu was homogeneous and the recovery of antigen-binding activity was 41-52%. The molecular mass of F(ab')2 mu was estimated to be 147-153 kDa, and we concluded that the fragment was composed of two truncated H chains and two intact L chains. F(ab')2 mu was used in an enzyme immunoassay of mouse interleukin-6 and the interaction of IgM with non-specific proteins was greatly reduced, when it was converted to F(ab')2 mu fragments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195591     DOI: 10.1016/0022-1759(94)90043-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Flow cytometric analysis of sialyl Lewis A antigen on human cancer cells by using F(ab')2μ fragments prepared from a mouse IgM monoclonal antibody.

Authors:  K Morimoto; K Inouye
Journal:  Cytotechnology       Date:  1997-09       Impact factor: 2.058

2.  Deletion of the κ genes from mouse hybridomas established with NS-1 myelomas.

Authors:  S Ohnaka; E Soga; K Inouye
Journal:  Cytotechnology       Date:  1997-09       Impact factor: 2.058

3.  Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.

Authors:  Demet Candas-Green; Bowen Xie; Jie Huang; Ming Fan; Aijun Wang; Cheikh Menaa; Yanhong Zhang; Lu Zhang; Di Jing; Soheila Azghadi; Weibing Zhou; Lin Liu; Nian Jiang; Tao Li; Tianyi Gao; Colleen Sweeney; Rulong Shen; Tzu-Yin Lin; Chong-Xian Pan; Omer M Ozpiskin; Gayle Woloschak; David J Grdina; Andrew T Vaughan; Ji Ming Wang; Shuli Xia; Arta M Monjazeb; William J Murphy; Lun-Quan Sun; Hong-Wu Chen; Kit S Lam; Ralph R Weichselbaum; Jian Jian Li
Journal:  Nat Commun       Date:  2020-09-14       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.